Are visual functions diagnostic signs of the minimally conscious state? an integrative review Berno U. H. OverbeekHenk J. EilanderRaymond T. C. M. Koopmans Review Open access 28 February 2018 Pages: 1957 - 1975
Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson’s disease patients Patricia SulzerSara BeckerInga Liepelt-Scarfone Original Communication 23 June 2018 Pages: 1976 - 1984
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation Itay LotanJudith BrodyHadas Stiebel-Kalish Original Communication 25 June 2018 Pages: 1985 - 1988
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment Alberto RomagnoloMargherita FabbriLeonardo Lopiano Original Communication 26 June 2018 Pages: 1989 - 1997
SEEG-guided radiofrequency coagulation (SEEG-guided RF-TC) versus anterior temporal lobectomy (ATL) in temporal lobe epilepsy Alexis MolesMarc GuénotPierre Bourdillon Original Communication 26 June 2018 Pages: 1998 - 2004
Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson’s disease and their caregivers Rosella CiurleoFrancesco CoralloSilvia Marino Original Communication 27 June 2018 Pages: 2005 - 2014
Autonomic function testing in Friedreich’s ataxia Elisabetta IndelicatoAlessandra FanciulliSylvia Boesch Original Communication Open access 27 June 2018 Pages: 2015 - 2022
The effects of anodal tDCS over the supplementary motor area on gait initiation in Parkinson’s disease with freezing of gait: a pilot study Chiahao LuSommer L. Amundsen HuffmasterColum D. MacKinnon Original Communication 28 June 2018 Pages: 2023 - 2032
Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson’s disease and multiple system atrophy C. Alves Do RegoI. J. NamerM. Anheim Original Communication 28 June 2018 Pages: 2033 - 2039
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias Heike JacobiSophie Tezenas du MontcelThomas Klockgether Original Communication 29 June 2018 Pages: 2040 - 2051
Corticosteroids in chronic inflammatory demyelinating polyneuropathy G. G. A. van LieverlooS. PericF. Eftimov Original Communication Open access 02 July 2018 Pages: 2052 - 2059
Coordination and timing deficits in speech and swallowing in autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) Adam P. VogelNatalie RommelMatthis Synofzik Original Communication 02 July 2018 Pages: 2060 - 2070
Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis Ulf KallweitClaudio L. A. BassettiGert Jan Lammers Original Communication 04 July 2018 Pages: 2071 - 2078
Corpus callosal involvement is correlated with cognitive impairment in multiple system atrophy Kazuhiro HaraHirohisa WatanabeGen Sobue Original Communication 05 July 2018 Pages: 2079 - 2087
Dysfunctional inhibitory control in Parkinson’s disease patients with levodopa-induced dyskinesias Silvia PicazioViviana PonzoGiacomo Koch Original Communication 06 July 2018 Pages: 2088 - 2096
Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry Libin XiaoLizhen PanLingjing Jin Original Communication 09 July 2018 Pages: 2097 - 2105
The discriminative value of blood gas analysis parameters in the differential diagnosis of transient disorders of consciousness Karmele Olaciregui DagueR. SurgesO. Matz Original Communication 09 July 2018 Pages: 2106 - 2113
Low specificity of voltage-gated calcium channel antibodies in Lambert–Eaton myasthenic syndrome: a call for caution Rodica Di LorenzoKarin MenteAdham Jammoul Original Communication 09 July 2018 Pages: 2114 - 2119
The accuracy of the clinical diagnosis of Parkinson disease. The HUNT study Eldbjørg HustadAnne Heidi SkogholtJan O. Aasly Original Communication Open access 10 July 2018 Pages: 2120 - 2124
Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study Maryse FeronAnnabelle CouillandreGiovanni de Marco Original Communication 11 July 2018 Pages: 2125 - 2136
Cognitive and fatigue side effects of anti-epileptic drugs: an analysis of phase III add-on trials Rani A. SarkisYazel GoksenJong Woo Lee Original Communication 12 July 2018 Pages: 2137 - 2142
Sneddon syndrome and non-bacterial thrombotic endocarditis: a clinicopathological study José BercianoNuria Terán-Villagrá Letter to the Editors 06 July 2018 Pages: 2143 - 2145
Primary progressive freezing gait with impressive response to laser light visual cueing: a video case report Moisés León RuizMiguel Á. García-SoldevillaEsteban García-Albea Ristol Letter to the Editors 13 July 2018 Pages: 2146 - 2148
Telomere length as a modifier of age-at-onset in Huntington disease: a two-sample Mendelian randomization study N. Ahmad AzizPatrick Weydt Letter to the Editors 12 July 2018 Pages: 2149 - 2151
Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report Simonetta GalganiLuca ProsperiniClaudio Gasperini Letter to the Editors 17 July 2018 Pages: 2152 - 2153
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients Albulena BajramiMarco PitteriMassimiliano Calabrese Neurological Update 25 June 2018 Pages: 2154 - 2161
New treatments in Alzheimer’s disease William O. PickrellNeil P. Robertson Journal club Open access 21 August 2018 Pages: 2162 - 2163
Bernardino Ramazzini (1633–1714) Michele Augusto RivaMichael BelingheriRoberto Lucchini Pioneers in Neurology 11 January 2018 Pages: 2164 - 2165
Correction to: Effectiveness of Rotigotine plus intensive and goal‑based rehabilitation versus Rotigotine alone in “de‑novo” Parkinsonian subjects: a randomized controlled trial with 18‑month follow‑up D. FerrazzoliP. OrtelliG. Frazzitta Correction 17 August 2018 Pages: 2166 - 2166